Motley Fool Asset Management LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 18.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,248 shares of the medical equipment provider’s stock after acquiring an additional 2,983 shares during the quarter. Motley Fool Asset Management LLC’s holdings in Intuitive Surgical were worth $10,047,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in ISRG. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical during the 4th quarter valued at $82,517,000. Sycomore Asset Management boosted its holdings in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares during the last quarter. Exome Asset Management LLC boosted its holdings in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its stake in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
Analysts Set New Price Targets
Several research analysts recently weighed in on ISRG shares. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Bernstein Bank boosted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Piper Sandler reissued an “overweight” rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, UBS Group boosted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $611.86.
Intuitive Surgical Stock Performance
Shares of ISRG opened at $507.05 on Thursday. The stock has a market capitalization of $180.60 billion, a price-to-earnings ratio of 79.10, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock’s 50-day simple moving average is $550.11 and its 200 day simple moving average is $532.84.
Insider Transactions at Intuitive Surgical
In other news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by corporate insiders.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Energy and Oil Stocks Explained
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Why Invest in 5G? How to Invest in 5G Stocks
- The 3 Most Talked About Investments on WallStreetBets Right Now
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.